Paper
0
The impact of neoadjuvant chemotherapy on patients with T1N0M0 triple-negative and HER-2 positive breast cancer:a retrospective analysis based on the SEER database
Authors
Journal
Published
May 1, 2024
Show more
Save
Tip0
TipSave
Abstract
The utilization of neoadjuvant chemotherapy (NAC) originated in the treatment of locally advanced breast cancer (BC). Our study is designed to elucidate the effects of NAC on patients with T1N0M0 triple-negative and HER-2 positive BC.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.